Use of Eltrombopag for the Treatment of Poor Graft Function after Hematopoietic Stem Cell Transplantation in Children

04.29.21

Use of Eltrombopag for the Treatment of Poor Graft Function after Hematopoietic Stem Cell Transplantation in Children

by Alex Kadhim

Types, Clinical Features and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand- A 3-year Prospective Multicenter Study from

04.27.21

Types, Clinical Features and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand- A 3-year Prospective Multicenter Study from

by Alex Kadhim

Progression of Self-Management Learning Experiences of Young Adults Following an Allogeneic Hematopoietic Stem Cell Transplantation_A Qualitative Study

04.23.21

Progression of Self-Management Learning Experiences of Young Adults Following an Allogeneic Hematopoietic Stem Cell Transplantation_A Qualitative Study

by Alex Kadhim

MRD Negativity “Associated with Improved Organ Response” in AL Amyloidosis

04.22.21

MRD Negativity “Associated with Improved Organ Response” in AL Amyloidosis

by Eleanor Mayfield, ELS

Nanoparticle-Based BiTEs “May Overcome Limitations” of Current Immunotherapies

04.19.21

Nanoparticle-Based BiTEs “May Overcome Limitations” of Current Immunotherapies

by Eleanor Mayfield, ELS

Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

04.16.21

Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

by Alex Kadhim

MRD Positivity Associated with Worse Outcomes in Mantle Cell Lymphoma

04.15.21

MRD Positivity Associated with Worse Outcomes in Mantle Cell Lymphoma

by Eleanor Mayfield, ELS

Feasibility of an Intensified Myeloablative Conditioning Regimen Consisting of Busulfan, Fludarabine, Cytarabine, and Total Body Irradiation

04.14.21

Feasibility of an Intensified Myeloablative Conditioning Regimen Consisting of Busulfan, Fludarabine, Cytarabine, and Total Body Irradiation

by Alex Kadhim

Point–Counterpoint: BiTEs vs CAR T-cells

04.12.21

Point–Counterpoint: BiTEs vs CAR T-cells

by Eleanor Mayfield, ELS

Theme picker

Thank you to our sponsors

Amgen

pharmacyclics

incyte